BioPharmGuy logo
Sponsored By:
Trianni Inc.
Weekly Update Subscription
Emery Pharma
Cell Pathways is defunct.

Fate: Acquired by OSI Pharmaceuticals, Feb 2003, $32M


------------------
If you believe any of this information is incorrect, please let us know.